Tiziana Life Sciences (TLSA) Market Capitalization (2018 - 2025)

Tiziana Life Sciences has reported Market Capitalization for 8 years, with the latest figure at $179.6 million in Q4 2025.

• On a quarterly basis, Market Capitalization rose 130.13% year-over-year to $179.6 million in Q4 2025; TTM through Dec 2025 was $179.6 million, a 130.13% increase from a year earlier, with the FY2025 full-year figure at $179.6 million, up 130.13% from the prior year.
• Market Capitalization was $179.6 million for Q4 2025 at Tiziana Life Sciences, up from $176.1 million in the prior quarter.
• The five-year high for Market Capitalization was $457.3 million in Q2 2021, with the low at $57.7 million in Q4 2023.
• Average Market Capitalization over 5 years is $134.9 million, with a median of $86.4 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2025: Market Capitalization plunged 83.23% in 2022, then jumped 130.13% in 2025.
• Over 5 years, Market Capitalization stood at $98.2 million in 2021, then plunged by 37.5% to $61.4 million in 2022, then retreated by 5.92% to $57.7 million in 2023, then jumped by 35.16% to $78.0 million in 2024, then surged by 130.13% to $179.6 million in 2025.
• The last three Market Capitalization figures came in at $179.6 million (Q4 2025), $176.1 million (Q2 2025), and $78.0 million (Q4 2024), per Business Quant data.